Back to Search Start Over

Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy

Authors :
Manisha Korb
Allison Peck
Lindsay N. Alfano
Kenneth I. Berger
Meredith K. James
Nupur Ghoshal
Elise Healzer
Claire Henchcliffe
Shaida Khan
Pradeep P. A. Mammen
Sujata Patel
Gerald Pfeffer
Stuart H. Ralston
Bhaskar Roy
William W. Seeley
Andrea Swenson
Tahseen Mozaffar
Conrad Weihl
Virginia Kimonis
the VCP Standards of Care Working Group
Source :
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-15 (2022)
Publication Year :
2022
Publisher :
BMC, 2022.

Abstract

Abstract Valosin-containing protein (VCP) associated multisystem proteinopathy (MSP) is a rare inherited disorder that may result in multisystem involvement of varying phenotypes including inclusion body myopathy, Paget’s disease of bone (PDB), frontotemporal dementia (FTD), parkinsonism, and amyotrophic lateral sclerosis (ALS), among others. An international multidisciplinary consortium of 40+ experts in neuromuscular disease, dementia, movement disorders, psychology, cardiology, pulmonology, physical therapy, occupational therapy, speech and language pathology, nutrition, genetics, integrative medicine, and endocrinology were convened by the patient advocacy organization, Cure VCP Disease, in December 2020 to develop a standard of care for this heterogeneous and under-diagnosed disease. To achieve this goal, working groups collaborated to generate expert consensus recommendations in 10 key areas: genetic diagnosis, myopathy, FTD, PDB, ALS, Charcot Marie Tooth disease (CMT), parkinsonism, cardiomyopathy, pulmonology, supportive therapies, nutrition and supplements, and mental health. In April 2021, facilitated discussion of each working group’s conclusions with consensus building techniques enabled final agreement on the proposed standard of care for VCP patients. Timely referral to a specialty neuromuscular center is recommended to aid in efficient diagnosis of VCP MSP via single-gene testing in the case of a known familial VCP variant, or multi-gene panel sequencing in undifferentiated cases. Additionally, regular and ongoing multidisciplinary team follow up is essential for proactive screening and management of secondary complications. The goal of our consortium is to raise awareness of VCP MSP, expedite the time to accurate diagnosis, define gaps and inequities in patient care, initiate appropriate pharmacotherapies and supportive therapies for optimal management, and elevate the recommended best practices guidelines for multidisciplinary care internationally.

Subjects

Subjects :
Medicine

Details

Language :
English
ISSN :
17501172
Volume :
17
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Orphanet Journal of Rare Diseases
Publication Type :
Academic Journal
Accession number :
edsdoj.bf65cfbc490c497cb1d7639887c6cbbe
Document Type :
article
Full Text :
https://doi.org/10.1186/s13023-022-02172-5